| Stage | CSCO | % of rev | PEP | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $17.3B | 100.00% | $25.3B | 100.00% | PEP ×1.46 |
| Gross profit | $11.1B | 64.13% | $13.8B | 54.42% | CSCO +9.7pp |
| Operating income | $4.3B | 24.72% | $4.3B | 16.86% | CSCO +7.9pp |
| Pre-tax income | $4.9B | 28.59% | $3.9B | 15.45% | CSCO +13.1pp |
| Net income | $3.9B | 22.37% | $3.1B | 12.15% | CSCO +10.2pp |
| Stage | CSCO | PEP | Gap · A − B |
|---|---|---|---|
| Revenue | $17.3B100.00% | $25.3B100.00% | PEP ×1.46 |
| Gross profit | 64.13%$11.1B | 54.42%$13.8B | CSCO +9.7pp |
| Operating income | 24.72%$4.3B | 16.86%$4.3B | CSCO +7.9pp |
| Pre-tax income | 28.59%$4.9B | 15.45%$3.9B | CSCO +13.1pp |
| Net income |
| 22.37%$3.9B |
| 12.15%$3.1B |
| CSCO +10.2pp |
No shared counterparties.